Literature DB >> 29345179

Regulatory Support Improves Subsequent IRB Approval Rates in Studies Initially Deemed Not Ready for Review: A CTSA Institution's Experience.

Susan Sonne1, Stephanie Gentilin1, Royce R Sampson1, Leslie Bell1, Toni Mauney1, Summer Young1, Katherine Bright1, Patrick Flume1.   

Abstract

We evaluated the impact of a regulatory support service (known as the Regulatory Knowledge and Support [RKS] program), part of the Medical University of South Carolina's Clinical and Translational Science Award, on the success of Institutional Review Board (IRB) applications that have previously been deemed by the IRB to be Not Ready for Review (NRR). At the time of this evaluation, 77 studies had been deemed NRR, 53 of which came from trainees and junior faculty. All the applications that received regulatory support either received IRB approval or were deemed to not be research, and therefore did not require IRB review. In all, 39.1% (n = 18) of the research teams who did not accept regulatory support successfully received IRB approval. Providing regulatory support, particularly to trainees and junior faculty, may be associated with better success in obtaining IRB approval as well as preventing the unnecessary submission of projects that are not research and would therefore not require IRB review or approval.

Entities:  

Keywords:  Institutional Review Boards; clinical research; translational research

Mesh:

Year:  2018        PMID: 29345179      PMCID: PMC6309298          DOI: 10.1177/1556264617752725

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  2 in total

1.  The NJ Alliance for Clinical and Translational Science (NJ ACTS) experience: Responding at "warp speed" to COVID-19.

Authors:  Pragya Thaman; Barbara Tafuto; Céline Gélinas; Sunanda Gaur; Judith A Neubauer
Journal:  J Clin Transl Sci       Date:  2022-04-04

2.  A snapshot of U.S. IRB review of COVID-19 research in the early pandemic.

Authors:  Holly A Taylor; Kimberley Serpico; Holly Fernandez Lynch; John Baumann; Emily E Anderson
Journal:  J Clin Transl Sci       Date:  2021-09-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.